stockrowDolby Laboratories
DLB Industrials Specialty Business Services
Dolby Laboratories' revenue for fiscal 2025 (year ended September 2025) was $1.3 billion, up 5.92% from fiscal 2024.
- Revenue
- −3.34%
- EPS
- −37.5%
- Free cash flow
- +157.4%
Quarter to June 2026, against a year earlier
Follow DLB
Alert me
Dolby Laboratories (DLB) Return on equity
Dolby Laboratories's return on equity over the twelve months to 30 June 2026 was 8.69%, down 1.3 percentage points from fiscal 2025 (9.96%). Over the past ten years it has ranged from 1.85% (fiscal 2018) to 12.3% (fiscal 2021); the current reading is higher than 55% of that period. That is above the Specialty Business Services industry median of 0.00% and above the Industrials sector median of 3.91%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 9.96% | (0.82) |
| FY2024 | 10.8% | 2.10 |
| FY2023 | 8.68% | 1.10 |
| FY2022 | 7.58% | (4.72) |
| FY2021 | 12.3% | 2.56 |
| FY2020 | 9.74% | (1.16) |
| FY2019 | 10.9% | 9.05 |
| FY2018 | 1.85% | (8.17) |
| FY2017 | 10.0% | 0.22 |
| FY2016 | 9.80% | (0.43) |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| MMS Maximus, Inc. compare | 21.1% |
| AZZ AZZ Inc. compare | 12.3% |
| ABM ABM Industries Incorporated compare | 9.19% |
| DLB Dolby Laboratories | 8.69% |
| CBZ CBIZ, Inc. compare | 7.29% |
| UNF Unifirst Corporation compare | 4.98% |
| AMTM Amentum Holdings, Inc. compare | 4.35% |
| FA First Advantage Corporation compare | 1.94% |
| RTO Rentokil Initial PLC compare | 0.00% |
| Specialty Business Services industry median | 0.00% |
| Industrials sector median | 3.91% |
| Market median | 1.07% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on DLB
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement